Trial Watch: Adoptively transferred cells for anticancer immunotherapy
Sign Up to like & getrecommendations! Published in 2017 at "OncoImmunology"
DOI: 10.1080/2162402x.2017.1363139
Abstract: ABSTRACT Immunotherapies aimed at strengthening immune effector responses against malignant cells are growing at exponential rates. Alongside, the impressive benefits obtained by patients with advanced melanoma who received adoptively transferred tumor-infiltrating lymphocytes (TILs) have encouraged… read more here.
Keywords: trial watch; act; watch adoptively; adoptively transferred ... See more keywords